Antibody Discovery Market
According to Intent Market Research, the Antibody Discovery Market is expected to grow from USD 4.9 Billion in 2023 at a CAGR of 19.4% to touch USD 17.0 Billion by 2030. The Antibody Discovery Market is dominated by key players such as Abcam, Adimab LLC, Amgen, Biogen Idec, Bristol Myers Squibb, Eli Lilly, Genmab, Lonza, MedImmune (AstraZeneca), Merck & Co., Novartis, Regeneron Pharmaceuticals and WuXi AppTec.